Thursday, February 04, 2016 11:05:47 PM
Mike Hunkapiller, CEO, Pacific Biosciences
Chapters:
0:00 When did you first encounter the idea to sequence the entire human genome?
5:09 Were you pushing Craig, or was he pushing you?
7:47 Definition of sequencing has changed in the past 15 years
14:40 How big a deal are long reads?
19:15 Will PacBio take over the research market?
24:32 What’s been the biggest surprise of your career?
We’re all familiar with the announcement in the year 2000 by US President, Bill Clinton, and the UK’s Prime Minister, Tony Blair, that scientists had completed the first draft of the human genome. It was a big deal. But the actual publications didn’t happen until the next year, February of 2001. Which means that this February is the fifteenth anniversary of the publication of the first human genome. For our commemorative show we’re joined by Mike Hunkapiller, the CEO of Pacific Biosciences.
Mike and his team at PacBio are coming off a great year. Their stock is up. Their long read sequencing technology is used for over a thousand scientific publications. And last year they launched a new better, faster, cheaper instrument, the Sequel, which are sold out through the first half of this year. PacBio is cool again.
How much were tool makers in the driving seat of the genomic revolution? And how much further can sequencing improve? Before asking Mike this, we explore some of his memories of those wild days when sequencing the human genome got presidents and prime ministers on the phone with their speech writers.
- See more at: http://mendelspod.com/podcasts/human-genome-turns-15-mike-hunkapiller-ceo-pacbio/#sthash.AIGUi9iX.6XBVg5Iw.dpuf
Submitted by Ayanna Monteverdi on Thu, 02/04/2016 - 09:36
- See more at: http://mendelspod.com/podcasts/human-genome-turns-15-mike-hunkapiller-ceo-pacbio/#sthash.AIGUi9iX.6XBVg5Iw.dpuf
Recent PACB News
- PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific • GlobeNewswire Inc. • 09/11/2024 01:05:00 PM
- Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital • GlobeNewswire Inc. • 09/04/2024 01:05:00 PM
- PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference • GlobeNewswire Inc. • 08/26/2024 08:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:27:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 09:25:47 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/19/2024 08:24:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/16/2024 08:29:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 12:46:25 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/07/2024 08:09:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:08:10 PM
- PacBio Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/07/2024 08:05:00 PM
- Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia • GlobeNewswire Inc. • 08/05/2024 08:05:00 PM
- Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing • GlobeNewswire Inc. • 07/23/2024 01:05:00 PM
- PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024 • GlobeNewswire Inc. • 07/15/2024 08:03:00 PM
- PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database • PR Newswire (US) • 06/10/2024 01:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/30/2024 01:52:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 09:25:43 PM
- Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases • PR Newswire (US) • 05/15/2024 01:45:00 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 05/09/2024 08:33:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:21:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:12:15 PM
- PacBio Announces First Quarter 2024 Financial Results • PR Newswire (US) • 05/09/2024 08:05:00 PM
- PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance • PR Newswire (US) • 04/16/2024 12:05:00 PM
- Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes • PR Newswire (US) • 03/27/2024 12:00:00 PM
- PacBio Grants Equity Incentive Award to New Employee • PR Newswire (US) • 03/22/2024 08:30:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM